摘要
众所周知,骨髓间质干细胞(MSCs)可帮助治疗组织损伤,常被称为流动性细胞。然而,MSCs也在癌细胞中出现从而对肿瘤生长和发展期产生相似的帮助。本综述描述了癌症发展和转移期的一些重要步骤,其中包括MSCs参与且可能起重要作用的各步。MSCs能提高癌细胞回避免疫攻击的能力,同时促进肿瘤血管生成,甚至对化疗和其他抗癌药产生反作用。此外,MSCs参与癌细胞侵袭和转移的多个关键步骤,其中包括刺激上皮-间质转化和诱导干细胞样性质,这种性质可使癌症干细胞在血循环中增加存活率。将对这些步骤进行详细描述。本文讨论了循环肿瘤细胞(CTCs)和肿瘤干细胞(CSCs)的不同之处,同时描述了转移前微环境的形成,即来自于癌细胞和转移期和肿瘤延续期的MSCs的外来体角色。越来越多的人提出将MSCs作为很有前途的肿瘤靶向给药工具。为了达到这一期望,对于MSCs在癌症转移进程中起的确切作用必须有更深层的理解,以期创建一些补救措施来提高现有疗法的疗效。
关键词: 癌症转移期,肿瘤干细胞,循环肿瘤细胞,外来体,间质干细胞,微环境。
图形摘要
Current Cancer Drug Targets
Title:Involvement of Mesenchymal Stem Cells in Cancer Progression and Metastases
Volume: 15 Issue: 2
Author(s): Astra I. Chang, Aaron H. Schwertschkow, Jan A. Nolta and Jian Wu
Affiliation:
关键词: 癌症转移期,肿瘤干细胞,循环肿瘤细胞,外来体,间质干细胞,微环境。
摘要: Mesenchymal stem/stromal cells (MSCs) are known to be the helpers for the healing of tissue damage, often referred to as ambulatory cells. However, MSCs are also recruited by cancer cells to similarly aid in tumor growth and progression. In this review, some of the key steps in cancer progression and metastases are described including the various steps in which MSCs participate and may play important roles. MSCs aid in cancer cells’ ability to evade immune attack, while promoting tumor angiogenesis, even being counter-acting against chemotherapeutics and other drugs used to fight various cancers. Furthermore, MSCs participate in many of the crucial steps in invasion and metastasis, including stimulating the epithelial-mesenchymal transition (EMT) and induction of stem-like properties that allow cancer stem cells to increase their survivability through the circulation. These steps are described in detail. Differences between circulating tumor cells (CTCs) and cancer stem cells (CSCs) are discussed, along with descriptions of the formation of a pre-metastatic niche, the role of exosomes from both cancer cells and MSCs in metastasis and tumor reseeding (self-seeding). More and more, MSCs are being proposed as a promising tumor targeting drug-delivery tool. In order to fulfill this promise, further understanding of the precise roles that MSCs play in the process of cancer metastases must be achieved, in attempting to create remedies that will improve the outcome of available therapeutics.
Export Options
About this article
Cite this article as:
Astra I. Chang, Aaron H. Schwertschkow, Jan A. Nolta and Jian Wu , Involvement of Mesenchymal Stem Cells in Cancer Progression and Metastases, Current Cancer Drug Targets 2015; 15 (2) . https://dx.doi.org/10.2174/1568009615666150126154151
DOI https://dx.doi.org/10.2174/1568009615666150126154151 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Brain Cancer-Activated Microglia: A Potential Role for Sphingolipids
Current Medicinal Chemistry Update on Laser Photochemotherapy: An Alternative for Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Intracellular Trafficking Mechanism and Cytosolic Protein Interactions of a Non Viral Gene Delivery Vector: Studies Based on Transferrin Conjugated Pullulan-PEI
Current Nanoscience Prospects of miRNA-Based Therapy for Pancreatic Cancer
Current Drug Targets Application of dsRNA in Cancer Immunotherapy: Current Status and Future Trends
Anti-Cancer Agents in Medicinal Chemistry Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
Current Chemical Biology <i>DBX2</i> Promotes Glioblastoma Cell Proliferation by Regulating <i>REST</i> Expression
Current Pharmaceutical Biotechnology Kinin Receptors in Vascular Biology and Pathology
Current Vascular Pharmacology Disulfiram's Anticancer Activity: Evidence and Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Marine Drugs: A Hidden Wealth and a New Epoch for Cancer Management
Current Drug Metabolism Biosafety of Herpesvirus Vectors
Current Gene Therapy Circular RNAs and Glioma: Small Molecule with Big Actions
Current Molecular Medicine Pyrimidine Nucleosides in Molecular PET Imaging of Tumor Proliferation
Current Medicinal Chemistry Manipulation of Glycolysis in Malignant Tumors: Fantasy or Therapy?
Current Medicinal Chemistry Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Biomimetic Drug Delivery Systems Oriented by Biological Function in Tumor Targeting
Current Drug Targets Synthesis and Biological Evaluation of Triazole-Vanillin Molecular Hybrids as Anti-Cancer Agents
Current Bioactive Compounds Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in Cancer
Recent Patents on Anti-Cancer Drug Discovery Advanced Micro-Nano-Bio Systems for Future Targeted Therapies
Current Nanoscience Ganglioside GD3 as a Raft Component in Cell Death Regulation
Anti-Cancer Agents in Medicinal Chemistry